Renoprotective effect of the xanthine oxidoreductase inhibitor Topiroxostat under decreased angiotensin II type 1a receptor expression-Reference-Cited by-同舟云学术

Renoprotective effect of the xanthine oxidoreductase inhibitor Topiroxostat under decreased angiotensin II type 1a receptor expression

Published:2017-11 Issue: Volume:815 Page:88-97
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Ohata Keiichi,Kamijo-Ikemori Atsuko,Sugaya Takeshi,Hibi Chihiro,Nakamura Takashi,Murase Takayo,Oikawa Tsuyoshi,Hoshino Seiko,Katayama Kimie,Asano Junko,Kimura Kenjiro,Shibagaki Yugo

Publisher

Elsevier BV

Subject

Pharmacology

Reference44 articles.

1. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial;Agodoa;JAMA,2001

2. New model for adenine-induced chronic renal failure in mice, and the effect of gum acacia treatment thereon: comparison with rats;Ali;J. Pharmacol. Toxicol. Methods,2013

3. Long-term effects of renin-angiotensin system–blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in african americans;Appel;Arch. Intern. Med.,2008

4. Angiotensin-converting enzyme inhibition prevents glomerular-tubule disconnection and atrophy in passive heymann nephritis, an effect not observed with a calcium antagonist;Benigni;Am. J. Pathol.,2001

5. Hyperuricemia as an independent risk factor of chronic kidney disease in middle-aged and elderly population;Chang;Am. J. Med. Sci.,2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Topiroxostat improves glomerulosclerosis in type 2 diabetic Nagoya Shibata Yasuda mice with early diabetic kidney disease;European Journal of Pharmacology;2024-11

2. Adenine-induced animal model of chronic kidney disease: current applications and future perspectives;Renal Failure;2024-04-04

3. Urinary liver‐type fatty acid binding protein is a biomarker reflecting renal damage and the ameliorative effect of drugs at an early stage of histone‐induced acute kidney injury;Nephrology;2023-11-11

4. Agents for the Treatment of Gout: Current Advances and Future Perspectives;Journal of Medicinal Chemistry;2023-11-01

5. Increased Lung Uric Acid Deteriorates Pulmonary Arterial Hypertension;Journal of the American Heart Association;2021-12-07